MX9205084A - MUTANT RECEPTOR OF THE GROWTH FACTOR AND CONTAINING MEDICINAL PRODUCT - Google Patents

MUTANT RECEPTOR OF THE GROWTH FACTOR AND CONTAINING MEDICINAL PRODUCT

Info

Publication number
MX9205084A
MX9205084A MX9205084A MX9205084A MX9205084A MX 9205084 A MX9205084 A MX 9205084A MX 9205084 A MX9205084 A MX 9205084A MX 9205084 A MX9205084 A MX 9205084A MX 9205084 A MX9205084 A MX 9205084A
Authority
MX
Mexico
Prior art keywords
growth factor
medicinal product
mutant receptor
containing medicinal
mutant
Prior art date
Application number
MX9205084A
Other languages
Spanish (es)
Inventor
Axel Ullrich
Norbert Hugo Redemann
Original Assignee
Max Planck Ges Zur Forderung
Der Wissenschaften E V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Ges Zur Forderung, Der Wissenschaften E V filed Critical Max Planck Ges Zur Forderung
Publication of MX9205084A publication Critical patent/MX9205084A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MX9205084A 1991-09-05 1992-09-04 MUTANT RECEPTOR OF THE GROWTH FACTOR AND CONTAINING MEDICINAL PRODUCT MX9205084A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19914129533 DE4129533A1 (en) 1991-09-05 1991-09-05 MUTTED GROWTH FACTOR RECEPTOR AS A MEDICINAL PRODUCT AND ITS USE FOR TREATING CANCER

Publications (1)

Publication Number Publication Date
MX9205084A true MX9205084A (en) 1993-05-01

Family

ID=6439926

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205084A MX9205084A (en) 1991-09-05 1992-09-04 MUTANT RECEPTOR OF THE GROWTH FACTOR AND CONTAINING MEDICINAL PRODUCT

Country Status (12)

Country Link
EP (1) EP0667899A1 (en)
JP (1) JPH07502884A (en)
CN (1) CN1071586A (en)
AU (1) AU669857B2 (en)
CA (1) CA2117073A1 (en)
DE (1) DE4129533A1 (en)
FI (1) FI941053A (en)
MX (1) MX9205084A (en)
NO (1) NO940778L (en)
NZ (1) NZ244239A (en)
PT (1) PT100844A (en)
WO (1) WO1993005148A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465623B2 (en) 1995-05-02 2002-10-15 Garvan Institute Of Medical Research GDU, a novel signalling protein
AUPN274295A0 (en) * 1995-05-02 1995-05-25 Garvan Institute Of Medical Research GDU, a novel signalling protein
US6790614B1 (en) 1999-11-19 2004-09-14 Novartis Ag Selectable cell surface marker genes
CN101501211A (en) * 2004-03-31 2009-08-05 综合医院公司 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68926888T2 (en) * 1988-01-22 1997-01-09 Zymogenetics Inc Process for the production of secreted receptor analogs
WO1990008160A1 (en) * 1989-01-20 1990-07-26 Imperial Cancer Research Technology Ltd. Growth factor receptor-like peptides without tyrosine-kinase activity
GB9001466D0 (en) * 1990-01-23 1990-03-21 Erba Carlo Spa Extracellular form of the human fibroblast growth factor receptor
EP0474727B1 (en) * 1989-05-19 1997-07-23 Genentech, Inc. Her2 extracellular domain
CA2066428C (en) * 1989-09-08 2000-11-28 Bert Vogelstein Structural alterations of the egf receptor gene in human gliomas

Also Published As

Publication number Publication date
PT100844A (en) 1994-05-31
NO940778L (en) 1994-05-04
WO1993005148A1 (en) 1993-03-18
JPH07502884A (en) 1995-03-30
EP0667899A1 (en) 1995-08-23
NO940778D0 (en) 1994-03-04
CN1071586A (en) 1993-05-05
AU669857B2 (en) 1996-06-27
DE4129533A1 (en) 1993-03-11
AU2518592A (en) 1993-04-05
NZ244239A (en) 1995-07-26
CA2117073A1 (en) 1993-03-18
FI941053A0 (en) 1994-03-04
FI941053A (en) 1994-04-08

Similar Documents

Publication Publication Date Title
GB2255503B (en) Improved use of ß2-bronchodilator drugs
EP0469921A3 (en) Deodorant and product in which the deodorant is used
DE69233474D1 (en) Pharmaceutical composition containing S-nitrosoimmunoglobulins and use thereof
EP0498268A3 (en) 5-oxo-l-proline derivatives and pharmaceutical use thereof
EE03015B1 (en) Medicinal product and its preparation
HU00207A9 (en) Sulfonanilide derivatives and medicine
DE69218727D1 (en) Medicine container
HU9400478D0 (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
FR2576069B1 (en) SELF-LOCKING PRODUCT AND SELF-LOCKING THREADED ARTICLES
KR960702749A (en) Use of Natural Products and Related Synthetic Compounds for the Treatment of Cardiovascular Disease
ITMI922571A1 (en) PROCEDURE FOR THE MANUFACTURE OF A PUSH-DRAWER AND DEVICE FOR IMPLEMENTING THE PROCEDURE
MX9205084A (en) MUTANT RECEPTOR OF THE GROWTH FACTOR AND CONTAINING MEDICINAL PRODUCT
GB2257056B (en) Medico-surgical and sanitary articles and materials
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
NO921086D0 (en) PROCEDURE FOR THE PREPARATION AND USE OF SUBSTITUTED 2 ', 3'-DIDESOXY-5-TRIFLUORMYTYLURIDINES
MX9200214A (en) PHARMACEUTICAL PRODUCT INCLUDING GRANISETRON AND DEXAMETASONE.
HU9204072D0 (en) Terazole derivatives and medical preparatives containing them
ZA911956B (en) 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances
EP0644716A4 (en) Medical uses of trioxolane and diperoxide compounds.
AU1401792A (en) Synthetic fabrics and surgical/medical products made therefrom
NO933262D0 (en) PROCEDURE FOR THE PREPARATION OF ALKOSYMAGNESIUM HALOGENIDES
ITMI920261V0 (en) VAPORIZER FOR MEDICAL AND COSMETIC PURPOSES
HU9203050D0 (en) Thieno-cyclopentanole-oximes and pharmaceutical preparatives containing them
ITMI912652A0 (en) MEDICINAL PRODUCT WITH ANTIELASIC ACTIVITY
ZA928419B (en) Pharmaceutical substances or compositions and their use